7,531
Views
65
CrossRef citations to date
0
Altmetric
Research Article

Bioengineering commensal bacteria-derived outer membrane vesicles for delivery of biologics to the gastrointestinal and respiratory tract

, , , , , , , , , , , , & show all
Article: 1632100 | Received 20 Nov 2018, Accepted 10 Jun 2019, Published online: 24 Jun 2019

References

  • Kulp A, Kuehn MJ. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu Rev Microbiol. 2010;64:163–19. PubMed PMID: WOS:000284030600009; English.
  • Del Giudice G, Rappuoli R, Didierlaurent AM. Correlates of adjuvanticity: a review on adjuvants in licensed vaccines. Semin Immunol. 2018 May 22;39:14–21.
  • Ellis TN, Kuehn MJ. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev. 2010 Mar;74(1):81–94. PubMed PMID: WOS:000275120100004; English.
  • Haurat M, Elhenawy W, Feldman M. Prokaryotic membrane vesicles: new insights on biogenesis and biological roles. Biol Chem. 2014;396(2):95–109.
  • Olsen I, Amano A. Outer membrane vesicles - offensive weapons or good Samaritans? J Oral Microbiol. 2015;7:27468. PubMed PMID: 25840612; PubMed Central PMCID: PMCPMC4385126.
  • Elhenawy W, Debelyy MO, Feldman MF. Preferential packing of acidic glycosidases and proteases into bacteroides outer membrane vesicles. MBio. 2014;5(2):e00909–e00914. PubMed PMID: 24618254; PubMed Central PMCID: PMC3952158.
  • Rakoff-Nahoum S, Coyne MJ, Comstock LE. An ecological network of polysaccharide utilization among human intestinal symbionts. Curr Biol. 2014 Jan 6;24(1):40–49. PubMed PMID: 24332541; PubMed Central PMCID: PMC3924574.
  • Stentz R, Osborne S, Horn N, et al. A bacterial homolog of a eukaryotic inositol phosphate signaling enzyme mediates cross-kingdom dialog in the mammalian gut. Cell Rep. 2014 Feb 27;6(4):646–656. PubMed PMID: 24529702; PubMed Central PMCID: PMC3969271.
  • Bryant WA, Stentz R, Le Gall G, et al. In silico analysis of the small molecule content of outer membrane vesicles produced by Bacteroides thetaiotaomicron indicates an extensive metabolic link between microbe and host. Front Microbiol. 2017;8:2440. PubMed PMID: 29276507; PubMed Central PMCID: PMCPMC5727896.
  • Shen Y, Giardino Torchia ML, Lawson GW, et al. Outer membrane vesicles of a human commensal mediate immune regulation and disease protection. Cell Host Microbe. 2012 Oct 18;12(4):509–520. PubMed PMID: 22999859; PubMed Central PMCID: PMC3895402.
  • Hickey CA, Kuhn KA, Donermeyer DL, et al. Colitogenic Bacteroides thetaiotaomicron antigens access host immune cells in a sulfatase-dependent manner via outer membrane vesicles. Cell Host Microbe. 2015 May 13;17(5):672–680. PubMed PMID: 25974305; PubMed Central PMCID: PMC4432250.
  • Kaparakis-Liaskos M, Ferrero RL. Immune modulation by bacterial outer membrane vesicles. Nat Rev Immunol. 2015 Jun;15(6):375–387. PubMed PMID: 25976515.
  • Stentz R, Carvalho AL, Jones EJ, et al. Fantastic Voyage: the journey of intestinal microbiota-derived microvesicles through the body. Biochem Soc Trans. 2018;46(5): 1012-1-27.
  • Kesty NC, Kuehn MJ. Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles. J Biol Chem. 2004 Jan 16;279(3):2069–2076. PubMed PMID: WOS:000188005700062; English.
  • Collins BS. Gram-negative outer membrane vesicles in vaccine development. Discov Med. 2011 Jul;62:7–15. PubMed PMID: WOS:000208639700001; English.
  • de Kleijn ED, de Groot R, Labadie J, et al. Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age. Vaccine. 2000 Feb 14;18(15):1456–1466. PubMed PMID: WOS:000085195800005; English.
  • Sandbu S, Feiring B, Oster P, et al. Immunogenicity and safety of a combination of two serogroup B meningococcal outer membrane vesicle vaccines. Clin Vaccin Immunol. 2007 Sep;14(9):1062–1069. PubMed PMID: WOS:000249488400002; English.
  • Gerritzen MJH, Martens DE, Wijffels RH, et al. Bioengineering bacterial outer membrane vesicles as vaccine platform. Biotechnol Adv. 2017 Sep;35(5):565–574. PubMed PMID: 28522212.
  • Shoemaker NB, Getty C, Gardner JF, et al. Tn4351 transposes in bacteroides spp and mediates the integration of plasmid R751 into the Bacteroides chromosome. J Bacteriol. 1986 Mar;165(3):929–936. PubMed PMID: WOS:A1986A276700039; English.
  • Stentz R, Horn N, Cross K, et al. Cephalosporinases associated with outer membrane vesicles released by bacteroides spp. protect gut pathogens and commensals against beta-lactam antibiotics. J Antimicrob Chemother. 2015 Mar;70(3):701–709. PubMed PMID: 25433011; PubMed Central PMCID: PMC4319488.
  • Wegmann U, Horn N, Carding SR. Defining the bacteroides ribosomal binding site. Appl Environ Microbiol. 2013 Mar;79(6):1980–1989. PubMed PMID: WOS:000315454500026; English.
  • Wegmann U, Klein JR, Drumm I, et al. Introduction of peptidase genes from Lactobacillus delbrueckii subsp. lactis into Lactococcus lactis and controlled expression. Appl Environ Microbiol. 1999 Nov;65(11):4729–4733. PubMed PMID: 10543778; PubMed Central PMCID: PMCPMC91636.
  • Matrosovich M, Matrosovich T, Garten W, et al. New low-viscosity overlay medium for viral plaque assays. Virol J. 2006 Aug 31;3:63. PubMed PMID: 16945126; PubMed Central PMCID: PMCPMC1564390.
  • Stewart JP, Kipar A, Cox H, et al. Induction of tachykinin production in airway epithelia in response to viral infection. PLoS One. 2008;3(3):e1673. PubMed PMID: 18320026; PubMed Central PMCID: PMC2248620. eng.
  • Schmid AS, Hemmerle T, Pretto F, et al. Antibody-based targeted delivery of interleukin-4 synergizes with dexamethasone for the reduction of inflammation in arthritis. Rheumatology (Oxford). 2018 Apr 1;57(4):748–755. PubMed PMID: 29365185; PubMed Central PMCID: PMCPMC6104808.
  • Gil-Cruz C, Bobat S, Marshall JL, et al. The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response. Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9803–9808. PubMed PMID: WOS:000267045500047; English.
  • Kurtz JR, Petersen HE, Frederick DR, et al. Vaccination with a single CD4 T cell peptide epitope from a Salmonella type III-secreted effector protein provides protection against lethal infection. Infect Immun. 2014 Jun;82(6):2424–2433. PubMed PMID: WOS:000336378100029; English.
  • Barat S, Willer Y, Rizos K, et al. Immunity to intracellular Salmonella depends on surface-associated antigens. PLoS Pathog. 2012 Oct;8(10):e1002966. PubMed PMID: WOS:000310530300029; English.
  • Rollenhagen C, Sorensen M, Rizos K, et al. Antigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogen. Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8739–8744. PubMed PMID: WOS:000222037000045; English.
  • McSorley SJ, Cookson BT, Jenkins MK. Characterization of CD4(+) T cell responses during natural infection with Salmonella typhimurium. J Iimmunol. 2000 Jan 15;164(2):986–993. PubMed PMID: WOS:000084708600057; English.
  • Paramasivam N, Linke D. ClubSub-P: cluster-based subcellular localization prediction for Gram-negative bacteria and archaea. Front Microbiol. 2011;2:218. PubMed PMID: WOS:000208863500226; English.
  • Burton NA, Schurmann N, Casse O, et al. Disparate impact of oxidative host defenses determines the fate of Salmonella during systemic infection in mice. Cell Host Microbe. 2014 Jan 15;15(1):72–83. PubMed PMID: WOS:000330854100010; English.
  • Lee SJ, McLachlan JB, Kurtz JR, et al. Temporal expression of bacterial proteins instructs host cd4 t cell expansion and Th17 development. PLoS Pathog. 2012 Jan;8(1):e1002499. PubMed PMID: WOS:000300767100039; English.
  • Reynolds CJ, Jones C, Blohmke CJ, et al. The serodominant secreted effector protein of Salmonella, SseB, is a strong CD4 antigen containing an immunodominant epitope presented by diverse HLA class II alleles. Immunology. 2014 Nov;143(3):438–446. PubMed PMID: WOS:000342894300013; English.
  • Mallajosyula VV, Citron M, Ferrara F, et al. Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection. Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):E2514–E2523. PubMed PMID: 24927560; PubMed Central PMCID: PMCPMC4078824.
  • Valkenburg SA, Mallajosyula VV, Li OT, et al. Stalking influenza by vaccination with pre-fusion headless HA mini-stem. Sci Rep. 2016 Mar 7;6:22666. PubMed PMID: 26947245; PubMed Central PMCID: PMCPMC4780079.
  • Werner S. Keratinocyte growth factor: a unique player in epithelial repair processes. Cytokine Growth Factor Rev. 1998 Jun;9(2):153–165. PubMed PMID: 9754709.
  • Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007 May 12;369(9573):1641–1657. PubMed PMID: 17499606.
  • Saroja C, Lakshmi P, Bhaskaran S. Recent trends in vaccine delivery systems: a review. Int J Pharm Investig. 2011 Apr;1(2):64–74. PubMed PMID: 23071924; PubMed Central PMCID: PMCPMC3465129.
  • Dieleman LA, Ridwan BU, Tennyson GS, et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology. 1994 Dec;107(6):1643–1652. PubMed PMID: 7958674.
  • Hamady ZZ, Scott N, Farrar MD, et al. Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus. Gut. 2010 Apr;59(4):461–469. PubMed PMID: 19736360.
  • Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98:694–702.
  • Hamady ZZ, Farrar MD, Whitehead TR, et al. Identification and use of the putative Bacteroides ovatus xylanase promoter for the inducible production of recombinant human proteins. Microbiology. 2008 Oct;154(Pt 10):3165–3174. PubMed PMID: 18832322.
  • Wegmann U, Carvalho AL, Stocks M, et al. Use of genetically modified bacteria for drug delivery in humans: revisiting the safety aspect. Sci Rep. 2017 May 23;7(1):2294. PubMed PMID: 28536456; PubMed Central PMCID: PMCPMC5442108.
  • Farrar M, Whithead TR, Lan J, et al. Engineering of the gut commensal bacterium Bacteroides ovatus to produce and secrete biologically active murine interluekin-2 in response to xylan. J Appl Microbiol. 2005;98:1191–1197.
  • Hamady ZZ, Scott N, Farrar MD, et al. Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-beta1 under the control of dietary xylan 1. Inflamm Bowel Dis. 2011 Sep;17(9):1925–1935. PubMed PMID: 21830271.
  • Ballesteros-Tato A, Leon B, Lund FE, et al. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat Immunol. 2010 Mar;11(3):216–224. PubMed PMID: 20098442; PubMed Central PMCID: PMCPMC2822886.
  • Brandtzaeg P. Gate-keeper function of the intestinal epithelium. Benef Microbes. 2013 Mar 1;4(1):67–82. PubMed PMID: 23257015.
  • Okamura M, Ueda M, Noda Y, et al. Immunization with outer membrane protein A from Salmonella enterica serovar Enteritidis induces humoral immune response but no protection against homologous challenge in chickens. Poult Sci. 2012 Oct;91(10):2444–2449. PubMed PMID: 22991526.
  • Sanders H, Feavers IM. Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines. Expert Rev Vaccines. 2011 Mar;10(3):323–334. PubMed PMID: 21434800.
  • Moshiri A, Dashtbani-Roozbehani A, Najar Peerayeh S, et al. Outer membrane vesicle: a macromolecule with multifunctional activity. Hum Vaccin Immunother. 2012 Jul;8(7):953–955. PubMed PMID: 22699443.
  • Krammer F, Palese P. Advances in the development of influenza virus vaccines. Nat Rev Drug Discov. 2015 Mar;14(3):167–182. PubMed PMID: 25722244.
  • Renegar KB, Small PA Jr., Boykins LG, et al. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol. 2004 Aug 1;173(3):1978–1986. PubMed PMID: 15265932.
  • Watkins HC, Rappazzo CG, Higgins JS, et al. Safe recombinant outer membrane vesicles that display M2e elicit heterologous influenza protection. Mol Ther. 2017 Apr 5;25(4):989–1002. PubMed PMID: 28215994; PubMed Central PMCID: PMCPMC5383554.
  • Zeeh JM, Procaccino F, Hoffmann P, et al. Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats. Gastroenterology. 1996 Apr;110(4):1077–1083. PubMed PMID: 8612996.
  • Miceli R, Hubert M, Santiago G, et al. Efficacy of keratinocyte growth factor-2 in dextran sulfate sodium-induced murine colitis. J Pharmacol Exp Ther. 1999 Jul;290(1):464–471. PubMed PMID: 10381813.